BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2991772)

  • 1. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice.
    Messing A; Chen HY; Palmiter RD; Brinster RL
    Nature; 1985 Aug 1-7; 316(6027):461-3. PubMed ID: 2991772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.
    Palmiter RD; Chen HY; Messing A; Brinster RL
    Nature; 1985 Aug 1-7; 316(6027):457-60. PubMed ID: 2991771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.
    Hanahan D
    Nature; 1985 May 9-15; 315(6015):115-22. PubMed ID: 2986015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice.
    Moore M; Teresky AK; Levine AJ; Seiberg M
    J Virol; 1992 Feb; 66(2):641-9. PubMed ID: 1370552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.
    Ornitz DM; Hammer RE; Messing A; Palmiter RD; Brinster RL
    Science; 1987 Oct; 238(4824):188-93. PubMed ID: 2821617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors.
    Brinster RL; Chen HY; Messing A; van Dyke T; Levine AJ; Palmiter RD
    Cell; 1984 Jun; 37(2):367-79. PubMed ID: 6327063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastase I promoter directs expression of human growth hormone and SV40 T antigen genes to pancreatic acinar cells in transgenic mice.
    Ornitz DM; Palmiter RD; Messing A; Hammer RE; Pinkert CA; Brinster RL
    Cold Spring Harb Symp Quant Biol; 1985; 50():399-409. PubMed ID: 3006998
    [No Abstract]   [Full Text] [Related]  

  • 8. Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
    Faas SJ; Pan S; Pinkert CA; Brinster RL; Knowles BB
    J Exp Med; 1987 Feb; 165(2):417-27. PubMed ID: 3029269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simian virus 40 T antigen is required for viral excision from chromosomes.
    Miller J; Bullock P; Botchan M
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7534-8. PubMed ID: 6095304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumors in hepatobiliary tract and pancreatic islet tissues of transgenic mice harboring gastrin simian virus 40 large tumor antigen fusion gene.
    Montag AG; Oka T; Baek KH; Choi CS; Jay G; Agarwal K
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6696-700. PubMed ID: 8393573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas.
    Casola S; Ungaro P; Pedone PV; Lazzaro D; Fattori E; Ciliberto G; Zarrilli R; Bruni CB; Riccio A
    Oncogene; 1995 Aug; 11(4):711-21. PubMed ID: 7651735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen.
    Brady J; Bolen JB; Radonovich M; Salzman N; Khoury G
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2040-4. PubMed ID: 6201850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of activated c-H-ras oncogene in hepatocellular carcinomas developing in transgenic mice harboring albumin promoter-regulated simian virus 40 gene.
    Lee GH; Li H; Ohtake K; Nomura K; Hino O; Furuta Y; Aizawa S; Kitagawa T
    Carcinogenesis; 1990 Jul; 11(7):1145-8. PubMed ID: 2164892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
    Ye X; McCarrick J; Jewett L; Knowles BB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.
    Efrat S; Fusco-DeMane D; Lemberg H; al Emran O; Wang X
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3576-80. PubMed ID: 7724601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocarcinogenesis in transgenic mice carrying albumin-promoted SV40 T antigen gene.
    Hino O; Kitagawa T; Nomura K; Ohtake K; Cui L; Furuta Y; Aizawa S
    Jpn J Cancer Res; 1991 Nov; 82(11):1226-33. PubMed ID: 1684356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
    Götz W; Schucht C; Roth J; Theuring F; Herken R
    Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.
    Sola C; Tronik D; Dreyfus M; Babinet C; Rougeon F
    Oncogene Res; 1989; 5(2):149-53. PubMed ID: 2558335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of human skeletal muscle cells with SV40 large T antigen gene coupled to a metallothionein promoter.
    Hurko O; McKee L; Zuurveld JG
    Ann Neurol; 1986 Nov; 20(5):573-82. PubMed ID: 3024558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen.
    Theuring F; Götz W; Balling R; Korf HW; Schulze F; Herken R; Gruss P
    Oncogene; 1990 Feb; 5(2):225-32. PubMed ID: 2157185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.